Jeffrey Gould Moore
Directeur Général chez Curileum Discovery Ltd
Postes actifs de Jeffrey Gould Moore
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Curileum Discovery Ltd
 Curileum Discovery Ltd Miscellaneous Commercial ServicesCommercial Services Curileum Discovery Ltd engages in research and development of novel therapeutic targets & drugs. The company was founded by Jeffrey Gould Moore on October 03, 2013 and is headquartered in Harrow, the United Kingdom. | Directeur/Membre du Conseil | 03/10/2013 | - |
| Directeur Général | 03/10/2013 | - |
Historique de carrière de Jeffrey Gould Moore
Anciens postes connus de Jeffrey Gould Moore
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENEDRIVE PLC | Directeur/Membre du Conseil | 01/09/2005 | 10/10/2013 |
| Corporate Officer/Principal | 18/10/2009 | 10/10/2013 | |
Phylogix, Inc.
 Phylogix, Inc. Pharmaceuticals: MajorHealth Technology Phylogix, Inc. develops therapeutic drugs. It conducts research on tissue protection and oncology. The firm develops drug candidates in preclinical development, called FRIL to protect cancer patients from the toxic side-effects of chemotherapy. The company was founded in 1998 and is headquartered in Waltham, MA | Fondateur | 01/01/1998 | 02/09/2009 |
| President | 01/01/1998 | 02/09/2009 | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/1992 | - |
Formation de Jeffrey Gould Moore
| George Washington University | Doctorate Degree |
| The Colorado College | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENEDRIVE PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Phylogix, Inc.
Phylogix, Inc. Pharmaceuticals: MajorHealth Technology Phylogix, Inc. develops therapeutic drugs. It conducts research on tissue protection and oncology. The firm develops drug candidates in preclinical development, called FRIL to protect cancer patients from the toxic side-effects of chemotherapy. The company was founded in 1998 and is headquartered in Waltham, MA | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Curileum Discovery Ltd
Curileum Discovery Ltd Miscellaneous Commercial ServicesCommercial Services Curileum Discovery Ltd engages in research and development of novel therapeutic targets & drugs. The company was founded by Jeffrey Gould Moore on October 03, 2013 and is headquartered in Harrow, the United Kingdom. | Commercial Services |
- Bourse
- Insiders
- Jeffrey Gould Moore
- Expérience
